Sticking With This Ondas Price Target After Sales Guidance Update
The small-cap firm crushed expectations, though with some mixed results.
Sticking With This Alto Ingredients Price Target Amid Turnaround
The small-cap firm enjoyed some strong results.
Buying More Rocket Lab After $397 Million Update
The aerospace firm has been awarded a significant contract by the U.S. Space Force.
Sticking With This Ocular Therapeutix Price Target as Key Treatment Moves Forward
The small-cap healthcare firm offered some encouraging earnings results.
Cutting SoFi as ‘Misleading’ Report Continues to Weight on Share Price
The financial services firm has taken a turn for the worse.
Our Small-Cap Drone Name Faces Opportunity After DoD Ramp Up Report
Though shares on under pressure on the news, there’s no long-term concern.
Selling 5 Small-Cap Names for a LIFO Profit
We looked to take advantage of some pre-earnings weakness and now we’re ready to profit.
Our Small-Cap Defense Name Surges After $70 Million Update
Plus, SoFi is set to release some important earnings data.
Buying More of This Small-Cap Name as Shares Fall Under Pressure
We’re also looking to take some profit after a $6.9 million update boosted another name.
Our Ocular Call Is Set to Expire as Market Struggles
We’re a bit handcuffed when it comes to making moves in our small-cap portfolio.